Wellnex Life Limited (ASX: $WNX) has released its half-year report and trading update, reporting a revenue of $5.7 million for the first half of FY24. The company's strategic decisions in the first half of FY24, including pivoting away from its historical brokerage business and the completion of the Pain Away transaction, have transformed the business, leading to a strong start to the second half of FY24.
The CEO, George Karafotias, stated, 'The first half of financial year 2024, while it had its challenges, was a pivotal moment for the Company. In the last 6 months we acquired the Pain Away business and transformed the Company into a totally focussed branded business. There is a strong Company focus to generate quality revenue that will add to the profitability of the organisation. Achieving our first operating profit in February is evidence we are on the right track with our aim and expectation to keep growing our margins and profits for the rest of this financial year and beyond.'
Wellnex Life Limited (ASX: $WNX) reported a revenue of $5.7 million for the first half of FY24, with a pivot away from its historical brokerage business. The completion of the Pain Away transaction has contributed to the company's transformation into a totally focused branded business, resulting in a strong start to the second half of FY24. The company anticipates increasing revenue, margins, and profitability for the remainder of FY24 and beyond, with a budgeted sales of $1.7 million for March and a focus on growing margins and profits.